Over 800 items to complete its bio-equivalent tests by year end.

Published: 2003-06-23 06:59:00

Updated: 2003-06-23 06:59:00

As of June 9 the total number of drugs having completed its bio-equivalency was 604, which will surpass more than 800 items by the end of this year as things are going this way.

The KFDA admitted that such a successful performance should be attributed to their effective explanatory meetings an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK